Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP).
Clinical trial NCT07278921 · RECRUITING
Trial details
- NCT number
- NCT07278921
- Sponsor
- Andrés José Maria Ferreri
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.